Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Sep 27, 2021; 13(9): 988-999
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.988
Table 1 Donor and simultaneous pancreas and kidney transplantation recipient clinical characteristics, n (%)
Characteristics
SL group (n = 44)
NSL group (n = 90)
P value
Donor age, yr34.00 ± 8.8232.32 ± 10.650.367
Donor gender (male/female, n)36/875/150.827
Recipient age, yr46.52 ± 9.5047.41 ± 10.790.643
Recipient gender (male/female, n)37/775/150.911
Duration of diabetes, yr16.73 ± 6.215.88 ± 5.90.449
Diabetes type (1/2)7/3718/720.568
BMI24.66 ± 3.6823.60 ± 3.180.089
Blood type, n
A+/B+/AB+/O+10/10/4/2017/35/10/280.169
Duration of dialysis, months, median (IQR)12.00 (6.25, 36.00)10.00 (5.00, 20.75)0.037
Pancreas ischemia time, minutes446.71 ± 104.11400.94 ± 89.790.010
HLA-A, -B, -DR mismatch
0-38 (18.18)19 (21.11)0.691
4-636 (81.82)71 (78.89)0.691
Maintenance Immunosupression
TAC40 (90.91)72 (80.00)0.109
CsA4 (9.09)18 (20.00)0.109
DIC indicators
PT-INR1.50 ± 0.371.55 ± 0.350.463
APTT (s)60.15 ± 35.1856.35 ± 38.390.582
TT (s)60.07 ± 37.9066.34 ± 37.030.362
PLT (109/L)106.41 ± 45.35108.94 ± 50.870.780